Slide 1FDA/Industry Workshop: Case Studies in M&S Copyright 2006, metrum research group LLC September 29, 2006 1 Exposure-Response (PK-PD) Applied to Model-Based Drug…

Slide 1Advances Against Aspergillosis Istanbul, 2012 Anti-fungal therapeutic drug monitoring and azole dose modification Tim Felton Slide 2 Advances Against Aspergillosis…

The exposome John Cherrie PDC Session: The exposome and exposure in the workplace Summary…   Cholera and Snow   Causation: from exposure to disease   Why…

1. 1Charles Oo OPTIMIZING THE TRANSITION FROM THE NONCLINICAL TO CLINICAL PHASES IN DRUG DEVELOPMENT Charles Oo, PharmD, PhD ABCP, FCP [email protected] 2. 2Charles Oo…

Slide 1 4th Kitasato-Harvard symposium on October 29, 2003 Japan Issues and Counter Measure for Real Implementation of Genome Based Clinical Trials Sanae Yasuda, PhD Eisai…

Slide 1 Occupational Exposure Limits & Other Reference Values Slide 2 Objective To explain occupational exposure limits and other reference values. Slide 3 Exposure Exposure…

Climate change and human health in search of magic numbers… NCAR Summer colloquium 28 July 2004 R Sari Kovats Centre on Global Change and Health Dept of Public Health and…

kohort

Climate change and human health in search of magic numbers… NCAR Summer colloquium 28 July 2004 R Sari Kovats Centre on Global Change and Health Dept of Public Health and…